ATE391510T1 - Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii - Google Patents

Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii

Info

Publication number
ATE391510T1
ATE391510T1 AT04708771T AT04708771T ATE391510T1 AT E391510 T1 ATE391510 T1 AT E391510T1 AT 04708771 T AT04708771 T AT 04708771T AT 04708771 T AT04708771 T AT 04708771T AT E391510 T1 ATE391510 T1 AT E391510T1
Authority
AT
Austria
Prior art keywords
diabetes
treatment
type
conglutin gamma
lupin conglutin
Prior art date
Application number
AT04708771T
Other languages
English (en)
Inventor
Paolo Morazzoni
Marcello Duranti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE391510T1 publication Critical patent/ATE391510T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT04708771T 2003-02-11 2004-02-06 Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii ATE391510T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000237A ITMI20030237A1 (it) 2003-02-11 2003-02-11 Uso della conglutina di lupino per il trattamento del

Publications (1)

Publication Number Publication Date
ATE391510T1 true ATE391510T1 (de) 2008-04-15

Family

ID=32866063

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04708771T ATE391510T1 (de) 2003-02-11 2004-02-06 Verwendung eines lupinkonglutins für die behandlung von diabetes typ ii

Country Status (21)

Country Link
US (1) US7323441B2 (de)
EP (1) EP1605957B1 (de)
JP (2) JP2006517212A (de)
KR (2) KR20110033312A (de)
CN (1) CN1747739B (de)
AT (1) ATE391510T1 (de)
AU (1) AU2004212297B2 (de)
CA (1) CA2515607C (de)
CY (1) CY1108138T1 (de)
DE (1) DE602004012984T2 (de)
DK (1) DK1605957T3 (de)
ES (1) ES2303937T3 (de)
HK (1) HK1085927A1 (de)
IL (1) IL170200A (de)
IT (1) ITMI20030237A1 (de)
NO (1) NO333224B1 (de)
PL (1) PL214193B1 (de)
PT (1) PT1605957E (de)
RU (1) RU2339393C2 (de)
SI (1) SI1605957T1 (de)
WO (1) WO2004071521A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
EP2310037B1 (de) 2008-05-30 2014-07-23 Policlinico San Donato S.p.A.- Istituto di Ricovero e Cura a Carattere Scientifico Conglutin-gamma als medikament und nahrungsergänzung
EP3130396B1 (de) 2009-03-27 2021-03-17 Bend Research, Inc. Sprühtrocknungsverfahren
EP2611529B1 (de) 2010-09-03 2019-01-23 Bend Research, Inc. Sprühtrocknungsverfahren
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
EP2618924A1 (de) 2010-09-24 2013-07-31 Bend Research, Inc. Hochtemperatur-sprühtrocknungsverfahren und verfahren
PL2627201T3 (pl) * 2010-10-12 2018-05-30 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Kompozycja zawierająca polipeptyd przeciwdrobnoustrojowy
EP3160246A1 (de) 2014-06-30 2017-05-03 Prolupin GmbH Emulsion mit lupinenprotein
PT3212169T (pt) 2014-10-31 2021-05-06 Bend Res Inc Processo para formar domínios ativos dispersos numa matriz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
JPH0967252A (ja) * 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del

Also Published As

Publication number Publication date
HK1085927A1 (en) 2006-09-08
JP2012153715A (ja) 2012-08-16
CY1108138T1 (el) 2014-02-12
NO333224B1 (no) 2013-04-15
PT1605957E (pt) 2008-06-27
NO20053788D0 (no) 2005-08-10
DE602004012984D1 (de) 2008-05-21
PL214193B1 (pl) 2013-06-28
EP1605957A1 (de) 2005-12-21
RU2339393C2 (ru) 2008-11-27
CN1747739B (zh) 2013-04-17
RU2005125411A (ru) 2006-01-27
EP1605957B1 (de) 2008-04-09
AU2004212297B2 (en) 2009-09-10
ES2303937T3 (es) 2008-09-01
AU2004212297A1 (en) 2004-08-26
CA2515607A1 (en) 2004-08-26
PL377578A1 (pl) 2006-02-06
CA2515607C (en) 2013-10-15
ITMI20030237A1 (it) 2004-08-12
IL170200A (en) 2010-05-31
KR101084434B1 (ko) 2011-11-21
DE602004012984T2 (de) 2009-06-04
WO2004071521A1 (en) 2004-08-26
KR20110033312A (ko) 2011-03-30
SI1605957T1 (sl) 2008-08-31
JP5504301B2 (ja) 2014-05-28
US7323441B2 (en) 2008-01-29
KR20050106415A (ko) 2005-11-09
NO20053788L (no) 2005-11-11
JP2006517212A (ja) 2006-07-20
US20060142185A1 (en) 2006-06-29
CN1747739A (zh) 2006-03-15
DK1605957T3 (da) 2008-08-11

Similar Documents

Publication Publication Date Title
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
DK1455603T3 (da) Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
PL1898724T3 (pl) Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
IL172916A0 (en) Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance
DE60012301D1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
DE60333868D1 (de) Verwendung von tryptophanreichen peptiden aus molkenproteinhydrolysate zur behandlung von übergewicht und fettleibigkeit
TW200513197A (en) Amino acid supplementation for a healthy microbiota ecosystem
JP2017057147A (ja) ニンニク等、低塩分濃度の味噌、及びビタミンｂ１を含有する組成物
WO2012049430A3 (fr) Hydrolysats de proteines animales d'origine marine aux proprietes neuroprotectrices
TW200633645A (en) Increase in the protein proportion of animal organisms
AR045745A1 (es) Fracciones de leche y preparaciones de leche para el tratamiento y/o prevencion de las enfermedades mediadas por cox-2
WO2002089741A3 (en) Compositions and methods for enhancing drug delivery
TW200501973A (en) Method of improvement of blood circulation
ATE417619T1 (de) Sporopollenin enthaltende lösliche zusammensetzung und verwendung
WO2006010127A3 (en) Therapeutic compound and treatments
DK1644402T3 (da) Arginin/lysin-berigede peptider
EP1407677A3 (de) Teilhydrolysierte Fischgelatine enthaltende Zubereitungen und deren Verwendung
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
JP2017043593A (ja) 黒ニンニク及びビタミンｂ１を含有する組成物
Umar et al. Available online: www. ncribjare. org ISSN 2695-2122, e-ISSN: 2695-2114
NZ512402A (en) Vitamin C and other vitamin derivatives, arginine and other amino acids and magnesium and other trace elements used in the treatment of conditions caused by smooth muscle construction e.g. tinnitus and asthma bronchiale
Kamalaveni et al. Evaluation of Spirulina Supplemented Diet and Its Influence on Bioenergetics and Biochemical Parameters in the Fish Cirrhinus mrigala

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1605957

Country of ref document: EP